img

Global Organ Transplant Rejection Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Organ Transplant Rejection Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Organ Transplant Rejection Medicine have enhanced short-term graft survival and minimized the rate of acute organ transplant rejection.
Organ Transplant Rejection Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Organ Transplant Rejection Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Kidney Transplant and Bone Marrow Transplant are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Organ Transplant Rejection Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Organ Transplant Rejection Medicine key manufacturers include GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd., Astellas Pharma, Inc., Pfizer, Inc., AbbVie, Inc., Allergan plc., Bristol-Myers Squibb Company and Sanofi, etc. GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd. are top 3 players and held % sales share in total in 2022.
Organ Transplant Rejection Medicine can be divided into Steroids, Antibodies, mTOR Inhibitors and Antiproliferative Agents, etc. Steroids is the mainstream product in the market, accounting for % sales share globally in 2022.
Organ Transplant Rejection Medicine is widely used in various fields, such as Kidney Transplant, Bone Marrow Transplant, Liver Transplant and Heart Transplant, etc. Kidney Transplant provides greatest supports to the Organ Transplant Rejection Medicine industry development. In 2022, global % sales of Organ Transplant Rejection Medicine went into Kidney Transplant filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Organ Transplant Rejection Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline plc
Novartis AG
F. Hoffmann-La Roche Ltd.
Astellas Pharma, Inc.
Pfizer, Inc.
AbbVie, Inc.
Allergan plc.
Bristol-Myers Squibb Company
Sanofi
Segment by Type
Steroids
Antibodies
mTOR Inhibitors
Antiproliferative Agents
Calcineurin Inhibitors

Segment by Application


Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lung Transplant
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Organ Transplant Rejection Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Organ Transplant Rejection Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Organ Transplant Rejection Medicine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Organ Transplant Rejection Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Organ Transplant Rejection Medicine introduction, etc. Organ Transplant Rejection Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Organ Transplant Rejection Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Organ Transplant Rejection Medicine Market Overview
1.1 Organ Transplant Rejection Medicine Product Overview
1.2 Organ Transplant Rejection Medicine Market Segment by Type
1.2.1 Steroids
1.2.2 Antibodies
1.2.3 mTOR Inhibitors
1.2.4 Antiproliferative Agents
1.2.5 Calcineurin Inhibitors
1.3 Global Organ Transplant Rejection Medicine Market Size by Type
1.3.1 Global Organ Transplant Rejection Medicine Market Size Overview by Type (2024-2034)
1.3.2 Global Organ Transplant Rejection Medicine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Organ Transplant Rejection Medicine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Organ Transplant Rejection Medicine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Organ Transplant Rejection Medicine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Organ Transplant Rejection Medicine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Organ Transplant Rejection Medicine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Organ Transplant Rejection Medicine Sales Breakdown by Type (2024-2024)
2 Global Organ Transplant Rejection Medicine Market Competition by Company
2.1 Global Top Players by Organ Transplant Rejection Medicine Sales (2024-2024)
2.2 Global Top Players by Organ Transplant Rejection Medicine Revenue (2024-2024)
2.3 Global Top Players by Organ Transplant Rejection Medicine Price (2024-2024)
2.4 Global Top Manufacturers Organ Transplant Rejection Medicine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Organ Transplant Rejection Medicine Market Competitive Situation and Trends
2.5.1 Organ Transplant Rejection Medicine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Organ Transplant Rejection Medicine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Rejection Medicine as of 2022)
2.7 Date of Key Manufacturers Enter into Organ Transplant Rejection Medicine Market
2.8 Key Manufacturers Organ Transplant Rejection Medicine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Organ Transplant Rejection Medicine Status and Outlook by Region
3.1 Global Organ Transplant Rejection Medicine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Organ Transplant Rejection Medicine Historic Market Size by Region
3.2.1 Global Organ Transplant Rejection Medicine Sales in Volume by Region (2024-2024)
3.2.2 Global Organ Transplant Rejection Medicine Sales in Value by Region (2024-2024)
3.2.3 Global Organ Transplant Rejection Medicine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Organ Transplant Rejection Medicine Forecasted Market Size by Region
3.3.1 Global Organ Transplant Rejection Medicine Sales in Volume by Region (2024-2034)
3.3.2 Global Organ Transplant Rejection Medicine Sales in Value by Region (2024-2034)
3.3.3 Global Organ Transplant Rejection Medicine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Organ Transplant Rejection Medicine by Application
4.1 Organ Transplant Rejection Medicine Market Segment by Application
4.1.1 Kidney Transplant
4.1.2 Bone Marrow Transplant
4.1.3 Liver Transplant
4.1.4 Heart Transplant
4.1.5 Lung Transplant
4.1.6 Others
4.2 Global Organ Transplant Rejection Medicine Market Size by Application
4.2.1 Global Organ Transplant Rejection Medicine Market Size Overview by Application (2024-2034)
4.2.2 Global Organ Transplant Rejection Medicine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Organ Transplant Rejection Medicine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Organ Transplant Rejection Medicine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Organ Transplant Rejection Medicine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Organ Transplant Rejection Medicine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Organ Transplant Rejection Medicine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Organ Transplant Rejection Medicine Sales Breakdown by Application (2024-2024)
5 North America Organ Transplant Rejection Medicine by Country
5.1 North America Organ Transplant Rejection Medicine Historic Market Size by Country
5.1.1 North America Organ Transplant Rejection Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Organ Transplant Rejection Medicine Sales in Volume by Country (2024-2024)
5.1.3 North America Organ Transplant Rejection Medicine Sales in Value by Country (2024-2024)
5.2 North America Organ Transplant Rejection Medicine Forecasted Market Size by Country
5.2.1 North America Organ Transplant Rejection Medicine Sales in Volume by Country (2024-2034)
5.2.2 North America Organ Transplant Rejection Medicine Sales in Value by Country (2024-2034)
6 Europe Organ Transplant Rejection Medicine by Country
6.1 Europe Organ Transplant Rejection Medicine Historic Market Size by Country
6.1.1 Europe Organ Transplant Rejection Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Organ Transplant Rejection Medicine Sales in Volume by Country (2024-2024)
6.1.3 Europe Organ Transplant Rejection Medicine Sales in Value by Country (2024-2024)
6.2 Europe Organ Transplant Rejection Medicine Forecasted Market Size by Country
6.2.1 Europe Organ Transplant Rejection Medicine Sales in Volume by Country (2024-2034)
6.2.2 Europe Organ Transplant Rejection Medicine Sales in Value by Country (2024-2034)
7 Asia-Pacific Organ Transplant Rejection Medicine by Region
7.1 Asia-Pacific Organ Transplant Rejection Medicine Historic Market Size by Region
7.1.1 Asia-Pacific Organ Transplant Rejection Medicine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Organ Transplant Rejection Medicine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Organ Transplant Rejection Medicine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Organ Transplant Rejection Medicine Forecasted Market Size by Region
7.2.1 Asia-Pacific Organ Transplant Rejection Medicine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Organ Transplant Rejection Medicine Sales in Value by Region (2024-2034)
8 Latin America Organ Transplant Rejection Medicine by Country
8.1 Latin America Organ Transplant Rejection Medicine Historic Market Size by Country
8.1.1 Latin America Organ Transplant Rejection Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Organ Transplant Rejection Medicine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Organ Transplant Rejection Medicine Sales in Value by Country (2024-2024)
8.2 Latin America Organ Transplant Rejection Medicine Forecasted Market Size by Country
8.2.1 Latin America Organ Transplant Rejection Medicine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Organ Transplant Rejection Medicine Sales in Value by Country (2024-2034)
9 Middle East and Africa Organ Transplant Rejection Medicine by Country
9.1 Middle East and Africa Organ Transplant Rejection Medicine Historic Market Size by Country
9.1.1 Middle East and Africa Organ Transplant Rejection Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Organ Transplant Rejection Medicine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Organ Transplant Rejection Medicine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Organ Transplant Rejection Medicine Forecasted Market Size by Country
9.2.1 Middle East and Africa Organ Transplant Rejection Medicine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Organ Transplant Rejection Medicine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GlaxoSmithKline plc
10.1.1 GlaxoSmithKline plc Company Information
10.1.2 GlaxoSmithKline plc Introduction and Business Overview
10.1.3 GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 GlaxoSmithKline plc Organ Transplant Rejection Medicine Products Offered
10.1.5 GlaxoSmithKline plc Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Novartis AG Organ Transplant Rejection Medicine Products Offered
10.2.5 Novartis AG Recent Development
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 F. Hoffmann-La Roche Ltd. Company Information
10.3.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.3.3 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Products Offered
10.3.5 F. Hoffmann-La Roche Ltd. Recent Development
10.4 Astellas Pharma, Inc.
10.4.1 Astellas Pharma, Inc. Company Information
10.4.2 Astellas Pharma, Inc. Introduction and Business Overview
10.4.3 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Products Offered
10.4.5 Astellas Pharma, Inc. Recent Development
10.5 Pfizer, Inc.
10.5.1 Pfizer, Inc. Company Information
10.5.2 Pfizer, Inc. Introduction and Business Overview
10.5.3 Pfizer, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pfizer, Inc. Organ Transplant Rejection Medicine Products Offered
10.5.5 Pfizer, Inc. Recent Development
10.6 AbbVie, Inc.
10.6.1 AbbVie, Inc. Company Information
10.6.2 AbbVie, Inc. Introduction and Business Overview
10.6.3 AbbVie, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 AbbVie, Inc. Organ Transplant Rejection Medicine Products Offered
10.6.5 AbbVie, Inc. Recent Development
10.7 Allergan plc.
10.7.1 Allergan plc. Company Information
10.7.2 Allergan plc. Introduction and Business Overview
10.7.3 Allergan plc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Allergan plc. Organ Transplant Rejection Medicine Products Offered
10.7.5 Allergan plc. Recent Development
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Company Information
10.8.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.8.3 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Products Offered
10.8.5 Bristol-Myers Squibb Company Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Sanofi Organ Transplant Rejection Medicine Products Offered
10.9.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Organ Transplant Rejection Medicine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Organ Transplant Rejection Medicine Industrial Chain Analysis
11.4 Organ Transplant Rejection Medicine Market Dynamics
11.4.1 Organ Transplant Rejection Medicine Industry Trends
11.4.2 Organ Transplant Rejection Medicine Market Drivers
11.4.3 Organ Transplant Rejection Medicine Market Challenges
11.4.4 Organ Transplant Rejection Medicine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Organ Transplant Rejection Medicine Distributors
12.3 Organ Transplant Rejection Medicine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Steroids
Table 2. Major Company of Antibodies
Table 3. Major Company of mTOR Inhibitors
Table 4. Major Company of Antiproliferative Agents
Table 5. Major Company of Calcineurin Inhibitors
Table 6. Global Organ Transplant Rejection Medicine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Organ Transplant Rejection Medicine Sales by Type (2024-2024) & (K Units)
Table 8. Global Organ Transplant Rejection Medicine Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Organ Transplant Rejection Medicine Sales by Type (2024-2024) & (US& Million)
Table 10. Global Organ Transplant Rejection Medicine Market Share in Value by Type (2024-2024)
Table 11. Global Organ Transplant Rejection Medicine Price by Type (2024-2024) & (USD/Unit)
Table 12. Global Organ Transplant Rejection Medicine Sales by Type (2024-2034) & (K Units)
Table 13. Global Organ Transplant Rejection Medicine Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Organ Transplant Rejection Medicine Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Organ Transplant Rejection Medicine Sales Market Share in Value by Type (2024-2034)
Table 16. Global Organ Transplant Rejection Medicine Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Organ Transplant Rejection Medicine Sales by Type (2024-2024) & (K Units)
Table 18. North America Organ Transplant Rejection Medicine Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Organ Transplant Rejection Medicine Sales (K Units) by Type (2024-2024)
Table 20. Europe Organ Transplant Rejection Medicine Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Organ Transplant Rejection Medicine Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Organ Transplant Rejection Medicine Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Organ Transplant Rejection Medicine Sales (K Units) by Type (2024-2024)
Table 24. Latin America Organ Transplant Rejection Medicine Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Organ Transplant Rejection Medicine Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Organ Transplant Rejection Medicine Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Organ Transplant Rejection Medicine Sales by Company (2024-2024) & (K Units)
Table 28. Global Organ Transplant Rejection Medicine Sales Share by Company (2024-2024)
Table 29. Global Organ Transplant Rejection Medicine Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Organ Transplant Rejection Medicine Revenue Share by Company (2024-2024)
Table 31. Global Market Organ Transplant Rejection Medicine Price by Company (2024-2024) & (USD/Unit)
Table 32. Global Organ Transplant Rejection Medicine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Organ Transplant Rejection Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Rejection Medicine as of 2022)
Table 35. Date of Key Manufacturers Enter into Organ Transplant Rejection Medicine Market
Table 36. Key Manufacturers Organ Transplant Rejection Medicine Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Organ Transplant Rejection Medicine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Organ Transplant Rejection Medicine Sales by Region (2024-2024) & (K Units)
Table 40. Global Organ Transplant Rejection Medicine Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Organ Transplant Rejection Medicine Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Organ Transplant Rejection Medicine Sales Market Share in Value by Region (2024-2024)
Table 43. Global Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 44. Global Organ Transplant Rejection Medicine Sales by Region (2024-2034) & (K Units)
Table 45. Global Organ Transplant Rejection Medicine Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Organ Transplant Rejection Medicine Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Organ Transplant Rejection Medicine Sales Market Share in Value by Region (2024-2034)
Table 48. Global Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Organ Transplant Rejection Medicine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Organ Transplant Rejection Medicine Sales by Application (2024-2024) & (K Units)
Table 51. Global Organ Transplant Rejection Medicine Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Organ Transplant Rejection Medicine Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Organ Transplant Rejection Medicine Sales Market Share in Value by Application (2024-2024)
Table 54. Global Organ Transplant Rejection Medicine Price by Application (2024-2024) & (USD/Unit)
Table 55. Global Organ Transplant Rejection Medicine Sales by Application (2024-2034) & (K Units)
Table 56. Global Organ Transplant Rejection Medicine Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Organ Transplant Rejection Medicine Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Organ Transplant Rejection Medicine Sales Market Share in Value by Application (2024-2034)
Table 59. Global Organ Transplant Rejection Medicine Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Organ Transplant Rejection Medicine Sales by Application (2024-2024) (K Units)
Table 61. North America Organ Transplant Rejection Medicine Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Organ Transplant Rejection Medicine Sales by Application (2024-2024) (K Units)
Table 63. Europe Organ Transplant Rejection Medicine Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Organ Transplant Rejection Medicine Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Organ Transplant Rejection Medicine Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Organ Transplant Rejection Medicine Sales by Application (2024-2024) (K Units)
Table 67. Latin America Organ Transplant Rejection Medicine Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Organ Transplant Rejection Medicine Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Organ Transplant Rejection Medicine Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Organ Transplant Rejection Medicine Sales by Country (2024-2024) & (K Units)
Table 71. North America Organ Transplant Rejection Medicine Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Organ Transplant Rejection Medicine Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Organ Transplant Rejection Medicine Sales Market Share in Value by Country (2024-2024)
Table 74. North America Organ Transplant Rejection Medicine Sales by Country (2024-2034) & (K Units)
Table 75. North America Organ Transplant Rejection Medicine Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Organ Transplant Rejection Medicine Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Organ Transplant Rejection Medicine Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Organ Transplant Rejection Medicine Sales by Country (2024-2024) & (K Units)
Table 79. Europe Organ Transplant Rejection Medicine Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Organ Transplant Rejection Medicine Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Organ Transplant Rejection Medicine Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Organ Transplant Rejection Medicine Sales by Country (2024-2034) & (K Units)
Table 83. Europe Organ Transplant Rejection Medicine Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Organ Transplant Rejection Medicine Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Organ Transplant Rejection Medicine Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Organ Transplant Rejection Medicine Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Organ Transplant Rejection Medicine Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Organ Transplant Rejection Medicine Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Organ Transplant Rejection Medicine Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Organ Transplant Rejection Medicine Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Organ Transplant Rejection Medicine Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Organ Transplant Rejection Medicine Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Organ Transplant Rejection Medicine Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Organ Transplant Rejection Medicine Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Organ Transplant Rejection Medicine Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Organ Transplant Rejection Medicine Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Organ Transplant Rejection Medicine Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Organ Transplant Rejection Medicine Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Organ Transplant Rejection Medicine Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Organ Transplant Rejection Medicine Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Organ Transplant Rejection Medicine Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share in Value by Country (2024-2034)
Table 110. GlaxoSmithKline plc Company Information
Table 111. GlaxoSmithKline plc Introduction and Business Overview
Table 112. GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 113. GlaxoSmithKline plc Organ Transplant Rejection Medicine Product
Table 114. GlaxoSmithKline plc Recent Development
Table 115. Novartis AG Company Information
Table 116. Novartis AG Introduction and Business Overview
Table 117. Novartis AG Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 118. Novartis AG Organ Transplant Rejection Medicine Product
Table 119. Novartis AG Recent Development
Table 120. F. Hoffmann-La Roche Ltd. Company Information
Table 121. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 122. F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 123. F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Product
Table 124. F. Hoffmann-La Roche Ltd. Recent Development
Table 125. Astellas Pharma, Inc. Company Information
Table 126. Astellas Pharma, Inc. Introduction and Business Overview
Table 127. Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 128. Astellas Pharma, Inc. Organ Transplant Rejection Medicine Product
Table 129. Astellas Pharma, Inc. Recent Development
Table 130. Pfizer, Inc. Company Information
Table 131. Pfizer, Inc. Introduction and Business Overview
Table 132. Pfizer, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 133. Pfizer, Inc. Organ Transplant Rejection Medicine Product
Table 134. Pfizer, Inc. Recent Development
Table 135. AbbVie, Inc. Company Information
Table 136. AbbVie, Inc. Introduction and Business Overview
Table 137. AbbVie, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 138. AbbVie, Inc. Organ Transplant Rejection Medicine Product
Table 139. AbbVie, Inc. Recent Development
Table 140. Allergan plc. Company Information
Table 141. Allergan plc. Introduction and Business Overview
Table 142. Allergan plc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 143. Allergan plc. Organ Transplant Rejection Medicine Product
Table 144. Allergan plc. Recent Development
Table 145. Bristol-Myers Squibb Company Company Information
Table 146. Bristol-Myers Squibb Company Introduction and Business Overview
Table 147. Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 148. Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Product
Table 149. Bristol-Myers Squibb Company Recent Development
Table 150. Sanofi Company Information
Table 151. Sanofi Introduction and Business Overview
Table 152. Sanofi Organ Transplant Rejection Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 153. Sanofi Organ Transplant Rejection Medicine Product
Table 154. Sanofi Recent Development
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Organ Transplant Rejection Medicine Market Trends
Table 158. Organ Transplant Rejection Medicine Market Drivers
Table 159. Organ Transplant Rejection Medicine Market Challenges
Table 160. Organ Transplant Rejection Medicine Market Restraints
Table 161. Organ Transplant Rejection Medicine Distributors List
Table 162. Organ Transplant Rejection Medicine Downstream Customers
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Rejection Medicine Product Picture
Figure 2. Global Organ Transplant Rejection Medicine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Organ Transplant Rejection Medicine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Organ Transplant Rejection Medicine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Steroids
Figure 6. Global Steroids Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Antibodies
Figure 8. Global Antibodies Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of mTOR Inhibitors
Figure 10. Global mTOR Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Antiproliferative Agents
Figure 12. Global Antiproliferative Agents Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Calcineurin Inhibitors
Figure 14. Global Calcineurin Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Organ Transplant Rejection Medicine Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Organ Transplant Rejection Medicine Sales Market Share by Type in 2022 & 2034
Figure 17. North America Organ Transplant Rejection Medicine Sales Market Share in Volume by Type in 2022
Figure 18. North America Organ Transplant Rejection Medicine Sales Market Share in Value by Type in 2022
Figure 19. Europe Organ Transplant Rejection Medicine Sales Market Share in Volume by Type in 2022
Figure 20. Europe Organ Transplant Rejection Medicine Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Organ Transplant Rejection Medicine Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Organ Transplant Rejection Medicine Sales Market Share in Value by Type in 2022
Figure 23. Latin America Organ Transplant Rejection Medicine Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Organ Transplant Rejection Medicine Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Organ Transplant Rejection Medicine Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Organ Transplant Rejection Medicine Revenue in 2022
Figure 29. Organ Transplant Rejection Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Kidney Transplant
Figure 31. Global Kidney Transplant Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Bone Marrow Transplant
Figure 33. Global Bone Marrow Transplant Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Liver Transplant
Figure 35. Global Liver Transplant Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Heart Transplant
Figure 37. Global Heart Transplant Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Product Picture of Lung Transplant
Figure 39. Global Lung Transplant Sales YoY Growth (2024-2034) & (K Units)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 42. Global Organ Transplant Rejection Medicine Sales by Application (2024-2034) & (US$ Million)
Figure 43. Global Organ Transplant Rejection Medicine Sales Market Share by Application in 2022 & 2034
Figure 44. North America Organ Transplant Rejection Medicine Sales Market Share in Volume by Application in 2022
Figure 45. North America Organ Transplant Rejection Medicine Sales Market Share in Value by Application in 2022
Figure 46. Europe Organ Transplant Rejection Medicine Sales Market Share in Volume by Application in 2022
Figure 47. Europe Organ Transplant Rejection Medicine Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Organ Transplant Rejection Medicine Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Organ Transplant Rejection Medicine Sales Market Share in Value by Application in 2022
Figure 50. Latin America Organ Transplant Rejection Medicine Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Organ Transplant Rejection Medicine Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Organ Transplant Rejection Medicine Manufacturing Cost Structure
Figure 55. Organ Transplant Rejection Medicine Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries